Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
about
Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [11 C]DASB PET study.Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [11C]DASB PK-PD Study.Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.
P2860
Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@en
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@nl
type
label
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@en
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@nl
prefLabel
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@en
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@nl
P2093
P2860
P1476
Altered serotonin transporter ...... reatment: [11C]DASB PET study.
@en
P2093
P2860
P304
P356
10.1017/S0033291715001865
P407
P577
2015-10-01T00:00:00Z